Viewing Study NCT06672705


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-04-04 @ 7:20 AM
Study NCT ID: NCT06672705
Status: RECRUITING
Last Update Posted: 2025-08-19
First Post: 2024-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders
Sponsor: Timothy Voorhees
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module